ONC BeOne Medicines Ltd.
Nasdaq · SEC CIK 1651308 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $361.20M 49 sales by 12 insiders
- Filings on record
- 271 since 2021-07-01, latest 2026-09-10 16:49
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| OYLER JOHN | CEO, Dir | — | $327.88M |
| Wang Xiaodong | Dir, COB, Scientific Advisory Brd | — | $13.37M |
| Wu Xiaobin | Pres, COO | — | $8.75M |
| Lee Chan Henry | SVP, GC | — | $7.95M |
| Wang Lai | Pres, Gbl Head of R, D | — | $1.17M |
| Sanders Corazon (Corsee) D. | Dir | — | $961.2K |
| Rosenberg Aaron | CFO | — | $524.4K |
| BAKER BROS. ADVISORS LP | Dir | — | $262.0K |
| Ball Titus B. | Principal Accounting Off | — | $127.3K |
| Dugan Margaret | Dir | — | $65.6K |
Transactions 336
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-26 | 2024-06-24 | ONC | Wang Julia Aijun | CFO | S - Sale | $155.66 | -899 | 0 | -100% | -$139.9K | |
| M | 2024-06-26 | 2024-06-24 | ONC | OYLER JOHN | CEO, Dir | S - Sale | $159.58 | -2,789 | 0 | -100% | -$445.1K |
| M | 2024-06-20 | 2024-06-17 | ONC | OYLER JOHN | CEO, Dir | S - Sale | $159.35 | -1,281 | 376 | -77% | -$204.1K |
| M | 2024-06-20 | 2024-06-17 | ONC | Lee Chan Henry | SVP, GC | S - Sale | $159.35 | -439 | 129 | -77% | -$70.0K |
| M | 2024-06-20 | 2024-06-17+ | ONC | Wu Xiaobin | Pres, COO, GM China | S - Sale | $155.26 | -3,254 | 300 | -92% | -$505.2K |
| M | 2024-06-20 | 2024-06-17 | ONC | Wang Julia Aijun | CFO | S - Sale | $159.04 | -916 | 762 | -55% | -$145.7K |
| M | 2024-06-20 | 2024-06-17+ | ONC | Wang Lai | Gbl Head of R, D | S - Sale | $157.27 | -2,341 | 1,626 | -59% | -$368.2K |
| D | 2024-06-07 | 2024-06-05 | ONC | Riva Alessandro | Dir | A - Grant | $0.00 | +16.3K | 46.0K | +55% | $0 |
| D | 2024-06-07 | 2024-06-05 | ONC | Ball Titus B. | Principal Accounting Off | A - Grant | $0.00 | +24.4K | 47.9K | +104% | $0 |
| D | 2024-06-07 | 2024-06-05 | ONC | Wang Julia Aijun | CFO | A - Grant | $0.00 | +136.2K | 456.3K | +43% | $0 |
| D | 2024-06-07 | 2024-06-05 | ONC | Glazer Donald W. | Dir | A - Grant | $0.00 | +16.3K | 2.72M | +0.6% | $0 |
| DMI | 2024-06-07 | 2024-06-05 | ONC | BAKER BROS. ADVISORS LP | Dir, 10% | A - Grant | $0.00 | +65.4K | 126.1K | +108% | $0 |
| D | 2024-06-07 | 2024-06-05 | ONC | Lee Chan Henry | SVP, GC | A - Grant | $0.00 | +98.1K | 269.4K | +57% | $0 |
| D | 2024-06-07 | 2024-06-05 | ONC | Wu Xiaobin | Pres, COO, GM China | A - Grant | $0.00 | +253.4K | 1.27M | +25% | $0 |
| D | 2024-06-07 | 2024-06-05 | ONC | HOOPER ANTHONY C | Dir | A - Grant | $0.00 | +16.3K | 53.8K | +44% | $0 |
| D | 2024-06-07 | 2024-06-05 | ONC | Wang Lai | Gbl Head of R, D | A - Grant | $0.00 | +168.9K | 1.77M | +11% | $0 |
| D | 2024-06-07 | 2024-06-05 | ONC | Dugan Margaret | Dir | A - Grant | $0.00 | +16.3K | 46.0K | +55% | $0 |
| D | 2024-06-07 | 2024-06-05 | ONC | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | A - Grant | $0.00 | +109.0K | 5.57M | +2% | $0 |
| D | 2024-06-07 | 2024-06-05 | ONC | Yi Qingqing | Dir | A - Grant | $0.00 | +16.3K | 46.0K | +55% | $0 |
| D | 2024-06-07 | 2024-06-05 | ONC | OYLER JOHN | CEO, Dir | A - Grant | $0.00 | +490.5K | 1.81M | +37% | $0 |
| D | 2024-06-07 | 2024-06-05 | ONC | Sanders Corazon (Corsee) D. | Dir | A - Grant | $0.00 | +16.3K | 46.2K | +55% | $0 |
| D | 2024-06-07 | 2024-06-05 | ONC | BRANDICOURT OLIVIER | Dir | A - Grant | $0.00 | +16.3K | 16.3K | New | $0 |
| MI | 2024-04-11 | 2024-04-09+ | ONC | OYLER JOHN | CEO, Dir | S - Sale | $149.50 | -50.0K | 2,811 | -95% | -$7.48M |
| M | 2024-03-14 | 2024-03-12+ | ONC | OYLER JOHN | CEO, Dir | S - Sale | $167.36 | -50.0K | 500 | -99% | -$8.37M |
| 2024-03-13 | 2024-03-11 | ONC | Glazer Donald W. | Dir | G - Gift | $0.00 | -82.0K | 2.70M | -3% | $0 | |
| 2024-03-04 | 2024-02-29 | ONC | Wang Julia Aijun | CFO | S - Sale | $167.08 | -397 | 0 | -100% | -$66.3K | |
| I | 2023-12-04 | 2023-11-30 | ONC | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | J - Other | $0.00 | -172.4K | 0 | -100% | $0 |
| 2023-12-04 | 2023-11-30 | ONC | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | G - Gift | $0.00 | -71.9K | 5.46M | -1% | $0 | |
| MI | 2023-11-14 | 2023-11-14 | ONC | Baker Brothers Life Sciences LP | Dir, 10% | S - Sale | $180.50 | -1.10M | 877.6K | -56% | -$198.55M |
| 2023-08-02 | 2023-07-31 | ONC | Lee Chan Henry | SVP, GC | S - Sale | $216.26 | -791 | 0 | -100% | -$171.1K | |
| 2023-07-06 | 2023-07-03 | ONC | Wang Julia Aijun | CFO | S - Sale | $179.55 | -472 | 0 | -100% | -$84.7K | |
| M | 2023-06-27 | 2023-06-23 | ONC | Sanders Corazon (Corsee) D. | Dir | S - Sale | $182.32 | -578 | 478 | -55% | -$105.4K |
| 2023-06-27 | 2023-06-26 | ONC | Wu Xiaobin | Pres, COO, GM China | S - Sale | $182.37 | -1,495 | 0 | -100% | -$272.6K | |
| 2023-06-27 | 2023-06-23 | ONC | Wang Julia Aijun | CFO | S - Sale | $182.85 | -840 | 0 | -100% | -$153.6K | |
| M | 2023-06-27 | 2023-06-26 | ONC | Wang Lai | Gbl Head of R, D | S - Sale | $181.92 | -1,108 | 5 | -100% | -$201.6K |
| DMI | 2023-06-20 | 2023-06-15 | ONC | 667, L.P. | Dir, 10% | A - Grant | $0.00 | +51.7K | 93.4K | +124% | $0 |
| D | 2023-06-20 | 2023-06-15 | ONC | Yi Qingqing | Dir | A - Grant | $0.00 | +12.9K | 29.6K | +77% | $0 |
| D | 2023-06-20 | 2023-06-15 | ONC | Wu Xiaobin | Pres, COO, GM China | A - Grant | $0.00 | +200.4K | 1.03M | +24% | $0 |
| D | 2023-06-20 | 2023-06-20 | ONC | Wu Xiaobin | Pres, COO, GM China | S - Sale | $192.44 | -1,753 | 0 | -100% | -$337.3K |
| D | 2023-06-20 | 2023-06-15 | ONC | Dugan Margaret | Dir | A - Grant | $0.00 | +12.9K | 29.6K | +77% | $0 |
| D | 2023-06-20 | 2023-06-15 | ONC | Glazer Donald W. | Dir | A - Grant | $0.00 | +12.9K | 2.78M | +0.5% | $0 |
| D | 2023-06-20 | 2023-06-15 | ONC | HOOPER ANTHONY C | Dir | A - Grant | $0.00 | +12.9K | 37.4K | +53% | $0 |
| D | 2023-06-20 | 2023-06-15 | ONC | Malley Thomas | Dir | A - Grant | $0.00 | +12.9K | 46.7K | +38% | $0 |
| D | 2023-06-20 | 2023-06-15 | ONC | Wang Lai | Gbl Head of R, D | A - Grant | $0.00 | +133.6K | 1.61M | +9% | $0 |
| D | 2023-06-20 | 2023-06-20 | ONC | Wang Lai | Gbl Head of R, D | S - Sale | $192.42 | -1,325 | 0 | -100% | -$255.0K |
| D | 2023-06-20 | 2023-06-15 | ONC | Lee Chan Henry | SVP, GC | A - Grant | $0.00 | +65.6K | 181.6K | +57% | $0 |
| D | 2023-06-20 | 2023-06-15 | ONC | OYLER JOHN | CEO, Dir | A - Grant | $0.00 | +355.6K | 1.97M | +22% | $0 |
| D | 2023-06-20 | 2023-06-15 | ONC | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | A - Grant | $0.00 | +86.2K | 5.53M | +2% | $0 |
| D | 2023-06-20 | 2023-06-20 | ONC | Wang Julia Aijun | CFO | S - Sale | $192.54 | -190 | 0 | -100% | -$36.6K |
| D | 2023-06-20 | 2023-06-15 | ONC | Wang Julia Aijun | CFO | A - Grant | $0.00 | +107.8K | 342.3K | +46% | $0 |
| D | 2023-06-20 | 2023-06-15 | ONC | Sanders Corazon (Corsee) D. | Dir | A - Grant | $0.00 | +12.9K | 37.4K | +53% | $0 |
| D | 2023-06-20 | 2023-06-15 | ONC | Riva Alessandro | Dir | A - Grant | $0.00 | +12.9K | 29.6K | +77% | $0 |
| MI | 2023-06-15 | 2023-06-13+ | ONC | HHLR ADVISORS, LTD. | 10% | S - Sale | $188.88 | -1.20M | 142.89M | -0.8% | -$226.30M |
| MI | 2023-06-12 | 2023-06-08+ | ONC | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | 10% | S - Sale | $201.97 | -2.96M | 145.88M | -2% | -$597.18M |
| M | 2023-06-09 | 2023-06-07 | ONC | Wang Lai | Gbl Head of R, D | S - Sale | $224.74 | -462 | 227 | -67% | -$103.8K |
| M | 2023-06-09 | 2023-06-07 | ONC | Wu Xiaobin | Pres, COO, GM China | S - Sale | $224.73 | -3,291 | 2,760 | -54% | -$739.6K |
| 2023-05-10 | 2023-05-08 | ONC | Wu Xiaobin | Pres, COO, GM China | S - Sale | $253.72 | -7,000 | 0 | -100% | -$1.78M | |
| 2023-03-20 | 2023-03-16 | ONC | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | G - Gift | $0.00 | -67.4K | 5.45M | -1% | $0 | |
| DM | 2023-03-10 | 2023-03-08 | ONC | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale+OE | $226.03 | -67.6K | 43.8K | -61% | -$15.29M |
| D | 2023-03-10 | 2023-03-08 | ONC | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | M - OptEx | $0.13 | +67.6K | 67.6K | New | +$8,793 |
| 2023-03-03 | 2023-03-01 | ONC | Wang Julia Aijun | CFO | S - Sale | $240.21 | -343 | 0 | -100% | -$82.4K | |
| MI | 2023-01-17 | 2023-01-12 | ONC | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale | $260.52 | -5,000 | 901 | -85% | -$1.30M |
| MI | 2023-01-12 | 2023-01-10 | ONC | OYLER JOHN | CEO, Dir | S - Sale | $248.52 | -13.6K | 2,140 | -86% | -$3.38M |
| M | 2023-01-12 | 2023-01-10 | ONC | OYLER JOHN | CEO, Dir | S - Sale | $248.52 | -6,797 | 0 | -100% | -$1.69M |
| M | 2023-01-11 | 2023-01-09+ | ONC | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale | $251.36 | -5,000 | 100 | -98% | -$1.26M |
| M | 2022-12-29 | 2022-12-27+ | ONC | OYLER JOHN | CEO, Dir | S - Sale | $224.43 | -3,203 | 0 | -100% | -$718.9K |
| MI | 2022-12-29 | 2022-12-27+ | ONC | OYLER JOHN | CEO, Dir | S - Sale | $224.43 | -6,406 | 0 | -100% | -$1.44M |
| MI | 2022-12-15 | 2022-12-13 | ONC | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale | $211.32 | -3,013 | 1,621 | -65% | -$636.7K |
| 2022-11-30 | 2022-11-28 | ONC | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | G - Gift | $0.00 | -52.0K | 5.58M | -0.9% | $0 | |
| I | 2022-11-17 | 2022-11-15 | ONC | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale | $210.14 | -1,987 | 0 | -100% | -$417.5K |
| M | 2022-11-17 | 2022-11-15 | ONC | OYLER JOHN | CEO, Dir | S - Sale | $206.84 | -25.0K | 23.6K | -51% | -$5.17M |
| MI | 2022-11-17 | 2022-11-15 | ONC | OYLER JOHN | CEO, Dir | S - Sale | $206.82 | -4,928 | 0 | -100% | -$1.02M |
| MI | 2022-09-22 | 2022-09-20+ | ONC | OYLER JOHN | CEO, Dir | S - Sale | $152.13 | -50.0K | 0 | -100% | -$7.61M |
| 2022-09-08 | 2022-09-06 | ONC | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | G - Gift | $0.00 | -33.4K | 5.63M | -0.6% | $0 | |
| I | 2022-08-24 | 2022-08-22 | ONC | HHLR ADVISORS, LTD. | 10% | J - Other | $0.00 | +7,800 | 147.04M | +0.0% | $0 |
| 2022-08-24 | 2022-08-22 | ONC | Yi Qingqing | Dir | J - Other | $0.00 | -7,800 | 16.7K | -32% | $0 | |
| M | 2022-08-09 | 2022-08-05+ | ONC | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale | $197.91 | -11.1K | 4,500 | -71% | -$2.19M |
| MI | 2022-08-09 | 2022-08-05 | ONC | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale | $193.85 | -5,000 | 0 | -100% | -$969.3K |
| A | 2022-07-18 | 2022-07-01 | ONC | Wang Julia Aijun | CFO | S - Sale | $158.50 | -317 | 0 | -100% | -$50.2K |
| 2022-07-05 | 2022-07-01 | ONC | Wang Julia Aijun | CFO | S - Sale | $158.50 | -295 | 0 | -100% | -$46.8K | |
| 2022-06-28 | 2022-06-27 | ONC | Wang Lai | Gbl Head of R, D | S - Sale | $177.32 | -458 | 0 | -100% | -$81.2K | |
| D | 2022-06-24 | 2022-06-22 | ONC | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | A - Grant | $0.00 | +83.5K | 5.81M | +1% | $0 |
| D | 2022-06-24 | 2022-06-22 | ONC | Wu Xiaobin | Pres, COO, GM China | A - Grant | $0.00 | +187.9K | 987.9K | +23% | $0 |
| D | 2022-06-24 | 2022-06-22 | ONC | Malley Thomas | Dir | A - Grant | $0.00 | +16.7K | 33.8K | +98% | $0 |
| D | 2022-06-24 | 2022-06-22 | ONC | Glazer Donald W. | Dir | A - Grant | $0.00 | +16.7K | 2.77M | +0.6% | $0 |
| D | 2022-06-24 | 2022-06-22 | ONC | OYLER JOHN | CEO, Dir | A - Grant | $0.00 | +334.0K | 2.07M | +19% | $0 |
| D | 2022-06-24 | 2022-06-22 | ONC | Sanders Corazon (Corsee) D. | Dir | A - Grant | $0.00 | +16.7K | 24.5K | +214% | $0 |
| D | 2022-06-24 | 2022-06-22 | ONC | Yi Qingqing | Dir | A - Grant | $0.00 | +16.7K | 24.5K | +214% | $0 |
| D | 2022-06-24 | 2022-06-22 | ONC | HOOPER ANTHONY C | Dir | A - Grant | $0.00 | +16.7K | 24.5K | +214% | $0 |
| D | 2022-06-24 | 2022-06-22 | ONC | Dugan Margaret | Dir | A - Grant | $0.00 | +16.7K | 16.7K | New | $0 |
| D | 2022-06-24 | 2022-06-22 | ONC | Wang Julia Aijun | CFO | A - Grant | $0.00 | +104.4K | 245.6K | +74% | $0 |
| D | 2022-06-24 | 2022-06-22 | ONC | Riva Alessandro | Dir | A - Grant | $0.00 | +16.7K | 16.7K | New | $0 |
| DMI | 2022-06-24 | 2022-06-22 | ONC | 667, L.P. | Dir, 10% | A - Grant | $0.00 | +66.8K | 67.6K | +8,294% | $0 |
| D | 2022-06-24 | 2022-06-22 | ONC | Wang Lai | Gbl Head of R, D | A - Grant | $0.00 | +125.3K | 1.51M | +9% | $0 |
| M | 2022-06-22 | 2022-06-17+ | ONC | Wang Lai | Gbl Head of R, D | S - Sale | $145.35 | -1,168 | 0 | -100% | -$169.8K |
| M | 2022-06-22 | 2022-06-17+ | ONC | Wu Xiaobin | Pres, COO, GM China | S - Sale | $142.63 | -1,588 | 1,010 | -61% | -$226.5K |
| 2022-06-21 | 2022-06-17 | ONC | Wang Julia Aijun | CFO | S - Sale | $136.64 | -161 | 0 | -100% | -$22.0K | |
| 2022-06-08 | 2022-06-06 | ONC | Wu Xiaobin | Pres, COO, GM China | S - Sale | $141.99 | -3,410 | 0 | -100% | -$484.2K | |
| 2022-06-08 | 2022-06-06 | ONC | Wang Lai | Gbl Head of R, D | S - Sale | $142.00 | -660 | 0 | -100% | -$93.7K | |
| DM | 2022-05-19 | 2022-05-17 | ONC | Wang Lai | Gbl Head of R, D | M - OptEx | $3.26 | +1.23M | 1.41M | +707% | +$4.03M |
Purchase Sale Sale after option exercise All abbreviations